NRC Health Business Combination, Contingent Consideration, Liability, Current
NRC Health (NRC) had Business Combination, Contingent Consideration, Liability, Current of $540.00 thousand as of 2024-12-31, per its 10-K filed 2025-03-17.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent · last filed 2025-03-17
- 2024-12-31: Business Combination, Contingent Consideration, Liability, Current $540.00K.
- 2024-09-30: Business Combination, Contingent Consideration, Liability, Current $506.00K.
- 2023-12-31: Business Combination, Contingent Consideration, Liability, Current $0.00.
- 2021-09-30: Business Combination, Contingent Consideration, Liability, Current $1.98M.
| Period end | Business Combination, Contingent Consideration, Liability, Current |
|---|---|
| 2024-12-31 | $540.00K 10-K · filed 2025-03-17 |
| 2024-09-30 | $506.00K 10-Q · filed 2024-11-08 |
| 2023-12-31 | $0.00 10-K · filed 2025-03-17 |
| 2021-09-30 | $1.98M 10-Q · filed 2021-11-05 |
| 2021-06-30 | $1.97M 10-Q · filed 2021-08-06 |
| 2021-03-31 | $1.96M 10-Q · filed 2021-05-07 |
| 2020-12-31 | $0.00 10-Q · filed 2021-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |